Managing Diuretic Therapy in Patients with Electrolyte and Acid-Base Imbalances

Mechanism of Diuretic-Induced Acid-Base Disturbances

Most diuretics increase distal sodium delivery, leading to principal cells reabsorbing sodium and increasing H+ secretion and HCO3- reabsorption, resulting in metabolic alkalosis, as stated by the American Heart Association and the American College of Cardiology 1, 2
Volume depletion from diuretics increases angiotensin II and aldosterone, which further increases H+ secretion through angiotensin II binding to AT1 receptors and aldosterone upregulating H+-ATPase pumps, according to the American College of Cardiology 2, 3

The American College of Cardiology recommends performing frequent clinical and biochemical monitoring, particularly during the first month of diuretic therapy, to assess serum electrolytes, creatinine, and acid-base status 4, 5
Regular measurement of serum electrolytes, creatinine, and acid-base status is crucial, as suggested by the American College of Cardiology and the European Association for the Study of the Liver 6, 7

The American Heart Association recommends considering adding potassium-sparing diuretics or ACE inhibitors to manage hypokalemia, as stated in Circulation 1, 2
Providing potassium supplements for severe cases is suggested by the American College of Cardiology 2

The European Association for the Study of the Liver recommends temporarily discontinuing diuretics if serum sodium is <125 mmol/L, and providing volume expansion with normal saline for hypovolemic hyponatremia 5

The American College of Cardiology recommends a maximum weight loss of 0.5 kg/day in patients without edema and 1 kg/day in patients with edema during diuretic therapy 4, 5
Starting with low doses and increasing until urine output increases and weight decreases by 0.5-1.0 kg daily is suggested by the American Heart Association for heart failure patients 1, 3

The American College of Cardiology recommends considering intravenous administration, combination of loop and thiazide diuretics, higher doses of loop diuretics, and checking for medications that interfere with diuretic action to manage diuretic resistance 1, 2, 3, 6

The American College of Cardiology suggests using caution when starting diuretics in patients with renal impairment, hyponatremia, or potassium disturbances, and reducing diuretic doses to maintain patients with minimal or no fluid retention after mobilization of fluid 4, 5
The American Heart Association recommends considering the goal of diuretic treatment to be elimination of clinical evidence of fluid retention 1, 3